Sajiv Krishnan Nair

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 6 EPO patents. Top assignees: Pfizer Corporation, Pharmacia & Upjohn Company, Agouron Pharmaceuticals, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sajiv Krishnan Nair. Retrieved from https://idiyas.com/inventor/sajiv-krishnan-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 52.9

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Kalamazoo, MI (US) (2002 - 2003)
Portage, MI (US) (2003 - 2005)
San Diego, CA (US) (2020 - 2022)
Vista, CA (US) (2008 - 2023)

Company Filing History:

Pharmacia & Upjohn Company

patents

1 out of 174

Agouron Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378232 - Cyclin dependent kinase inhibitors (2025-08-05),

2. 11684616 - Azalactam compounds as HPK1 inhibitors (2023-06-27),

3. 11396512 - CDK2/4/6 inhibitors (2022-07-26),

4. 11220494 - Cyclin dependent kinase inhibitors (2022-01-11),

5. 11203594 - Anti-proliferative agents for treating PAH (2021-12-21),

6. 11142525 - Azalactam compounds as HPK1 inhibitors (2021-10-12),

7. 10800783 - CDK2/4/6 inhibitors (2020-10-13),

8. 10766884 - Cyclin dependent kinase inhibitors (2020-09-08),

9. 9290496 - Purine derivatives (2016-03-22),

10. 9056865 - Pyridine-2-derivatives as smoothened receptor modulators (2015-06-16),

11. 9040547 - Pyrrolopyrimidine and purine derivatives (2015-05-26),

12. 7462634 - N-(pyridin-2-yl)-sulfonamide derivatives (2008-12-09),

13. 6878705 - 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents (2005-04-12),

14. 6683181 - Pyrroloquinolones as antiviral agents (2004-01-27),

15. 6624160 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents (2003-09-23),

Title: The Innovative Journey of Sajiv Krishnan Nair

Introduction

Sajiv Krishnan Nair is a prominent inventor based in Vista, California. With an impressive portfolio of 16 patents, he has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors targeting cyclin-dependent kinases, which play a crucial role in cell cycle regulation.

Latest Patents

Among his most notable inventions are the cyclin-dependent kinase inhibitors, which relate to compounds of Formula (I). Additionally, his work on CDK2/4/6 inhibitors pertains to compounds of general Formula (I). These inventions have the potential to impact cancer treatments significantly by inhibiting key enzymes involved in cell proliferation.

Career Highlights

Sajiv has had a distinguished career, working with leading pharmaceutical companies such as Pfizer Corporation and Pharmacia & Upjohn Company. His experience in these organizations has enabled him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Sajiv has collaborated with notable colleagues, including Mehran Jalaie and Ping Chen. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of groundbreaking pharmaceutical solutions.

Conclusion

Sajiv Krishnan Nair's contributions to the field of pharmaceuticals through his inventions and patents showcase his innovative spirit and dedication to advancing medical science. His work not only exemplifies the importance of collaboration in research but also highlights the potential of his inventions to transform cancer treatment strategies in the future.

Profile summary based on public USPTO records.